Ex-Goldman Sachs Trader With Brain Cancer Has "The Answer"

Published: Dec 03, 2010


That is, Gordon Murray, a former bond trader at Goldman Sachs who later worked at Lehman Brothers and CSFB and who "decided to cease all treatment five months ago for his glioblastoma, a type of brain cancer," recently published The Investment Answer.

According to the Times, "the mere fact that Mr. Murray felt compelled to write it is itself a remarkable story of an almost willful ignorance of the futility of active money management — and how he finally stumbled upon a better way of investing. Mr. Murray now stands as one the highest-ranking Wall Street veterans to take back much of what he and his colleagues worked for during their careers."

Even more fascinating than a book about how Goldman Sachs and Credit Suisse and other Wall Street titans have it all wrong when it comes to investing is the answer to this question: If you had less than a year left to live, how would you spend your dying days?

I'm not sure what I'd do, but I think this guy is on to something. Happy Friday.


Related Content

Content Type

25 Best Investment Banks to Work for in 2022

Today, we're excited to release our 2022 Banking 25, a ranking of the best investment banking firms to work for in North America. The ranking is based on a survey of more than 3,600 banking professionals.

Content Type

Why Fintech Is Growing So Fast and How to Break Into This White-Hot Industry

Brian Hamilton is the founder and CEO of One, a fintech startup that provides digital banking services to the shrinking U.S. middle class.

Content Type

50 Best Accounting Firms for 2022

Today, we release our annual Accounting 50, a ranking of the best accounting firms to work for. The ranking is based on a survey of approximately 11,400 accounting professionals, who were asked to rate their firms in several workplace categories, including business outlook, compensation, culture, hours, training, overall satisfaction, and work/life balance.